ArticleOncology reports2014

MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.

Fei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.